Evolution of the Average Target: Cardiol Therapeutics Inc.

Evolution of the Target Price: Cardiol Therapeutics Inc.

Changes in Analyst Recommendations: Cardiol Therapeutics Inc.

36b.YixluHXJcliUYS5q96cjJzC2DIXenASeZBHyy27DKTg.DBk2jjfxLRz8NmklsvMTSUmPWNe8ykiqCU6DvQGNWws1FDzUA4wjMNoJHg~25d8090be04355bec77362b59faada9f

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+229.67%
+24.99%
+11.38%
+29.66%
+16.86%
+50.89%
+20.22%
-10.56%
+1.85%
+8.69%
Average +38.37%
Weighted average by Cap. +20.52%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.740CAD
Average target price
6.000CAD
Spread / Average Target
+244.83%
High Price Target
7.000CAD
Spread / Highest target
+302.30%
Low Price Target
5.000CAD
Spread / Lowest Target
+187.36%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Canaccord Genuity
HC Wainwright
Cantor Fitzgerald
Raymond James
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.740CAD
Average target price
6.000CAD
Spread / Average Target
+244.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRDL Stock
  4. Consensus Cardiol Therapeutics Inc.